4.7 Review

Vitamin D, cognition, and dementia A systematic review and meta-analysis

期刊

NEUROLOGY
卷 79, 期 13, 页码 1397-1405

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31826c197f

关键词

-

资金

  1. Canadian Institutes of Health Research
  2. Agency for Healthcare Research and Quality
  3. Canada Foundation for Innovation (CFI)
  4. Ontario Ministry of Health and Long-Term Care
  5. Novartis
  6. Janssen-Ortho
  7. Schlegel Research Chair in Geriatric Medicine at the University of Waterloo
  8. Heart and Stroke Foundation of Ontario
  9. Nutrition Society
  10. American Society of Nutrition
  11. James Tudor Foundation
  12. Sir Halley Stewart Trust
  13. Norman Family Charitable Trust
  14. Peninsula Medical School Foundation
  15. Age Related Diseases and Health Trust

向作者/读者索取更多资源

Objective: To examine the association between cognitive function and dementia with vitamin D concentration in adults. Methods: Five databases were searched for English-language studies up to August 2010, and included all study designs with a comparative group. Cognitive function or impairment was defined by tests of global or domain-specific cognitive performance and dementia was diagnosed according to recognized criteria. A vitamin D measurement was required. Two authors independently extracted data and assessed study quality using predefined criteria. The Q statistic and I-2 methods were used to test for heterogeneity. We conducted meta-analyses using random effects models for the weighted mean difference (WMD) and Hedge's g. Results: Thirty-seven studies were included; 8 contained data allowing mean Mini-Mental State Examination (MMSE) scores to be compared between participants with vitamin D <50 nmol/L to those with values >= 50 nmol/L. There was significant heterogeneity among the studies that compared the WMD for MMSE but an overall positive effect for the higher vitamin D group (1.2, 95% confidence interval [CI] 0.5 to 1.9; I-2 = 0.65; p = 0.002). The small positive effect persisted despite several sensitivity analyses. Six studies presented data comparing Alzheimer disease (AD) to controls but 2 utilized a method withdrawn from commercial use. For the remaining 4 studies the AD group had a lower vitamin D concentration compared to the control group (WMD = -6.2 nmol/L, 95% CI -10.6 to -1.8) with no heterogeneity (I-2 < 0.01; p = 0.53). Conclusion: These results suggest that lower vitamin D concentrations are associated with poorer cognitive function and a higher risk of AD. Further studies are required to determine the significance and potential public health benefit of this association. Neurology (R) 2012;79:1397-1405

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据